gallopamil

This page covers all gallopamil drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sodium channel alpha subunits; brain (Types I, II, III).

Targets

Sodium channel alpha subunits; brain (Types I, II, III)

Phase 2 pipeline (1)

• Methoxyverapamil · Other
  Methoxyverapamil blocks sodium channels in the brain to reduce abnormal electrical activity.

Patent intelligence

• gallopamil patent landscape — aggregated cliff calendar, attackable patents, originator estates